XTMGS7ACE CHF INAV (I2PL) News

Lee is deserving and he is up.

u are right, Yahoo Finance isn't updated with that.

Quote of the day https://x.com/DavidJHarrisJr/status/1905617728574022063

https://www.stockscores.com/charts/charts/?ticker=AAGC

LOL not if he includes his autobiography :)

Give us a head's up. What's your prediction since you seem to have a real knack! lolololol

Put me down for 66000 — now 44k up 50% — so 66k

41,583.90 -715.80 (1.69%)today

Liar!! They could cure cancer...or invent a free energy device!

Any ideas on what it will do? Should open at $10, I'm trying to see if my brokerage will let me get in early.

Bullish, so far.

There will be a pullback and another run up.

I think we at least touch 3s next week

Steven and Frank-Off

Who can put out the most FAKE PRs?

Let's see

Frank put out 3 allegedly FAKE PRs on 2 mining operations MONI said they acquired.

I guess the Aeroplane scam about how it was going to save the OTC never panned out

I do. I also believe one of these weeks we jump big. JMHO 
GO $MCIC 

zero82,

Thanks for posting 😶

Do you really think it’s plausible that NWBO could be valued at “2 or 3 cents” while checkpoint inhibitors are worth tens of billions? Do these valuations align, given the combo data that are beginning to emerge? Two of NWBO’s novel

CUBT I have been more critical of this company than anyone on this board.

cough

Biden didn't have a blooming thing to do with this company's failure. They had an approved S-1 offering and uplisting, it was done. What they didn't have was investors to buy the stock fro

Swing traders are here. A little up and then down
Now range is 5 to 8
It will boost with name change then up listing on Nasdaq

arizona, is Taylor Swift really moving to Canada?.

Now put those shares up for @ .37

I'd slap @ .50

Countdown to MONDAY !!!!

NMAX, move over FOXNEWS

A fantastic future awaits NMAX shareholder

BIEL #7 BREAKOUT BOARD!

AACR in late April

CT251 / 20 - Phase 3 INTerpath-009 study: Individualized neoantigen therapy V940 (mRNA-4157) plus pembrolizumab for resected stage II-IIIB (N2) NSCLC with incomplete pathological response to neoadjuvant immunochemotherapy https://www.abstractsonline.com/pp8/#!/20273

BIEL #7 BREAKOUT BOARD!

April 5 https://investorshub.advfn.com/boards/profilea.aspx?user=719271

How would prioritizing 2-73 for the USA "screw the EMA"? There is plenty of 2-73 to go around and any country that approves it would see large benefits. If both the EMA and the FDA approve then both Europeans and Americans will benefit, right?

Agree that 2-73 would be a boon both fi

You bet — how about a double— 88k on the Dow on 11/01/2028 — for sure

Any guesses as to what we’ll see on the sem-annual this monday/tuesday?


More contracts to be signed soon? Possible link to TGLO? Exciting times ahead